FDA JUMPS ON AI BANDWAGON (Orthopedics This Week)
The FDA is going high tech.
According to Evan Sweeney, a writer for MedTech, the agency will use computer modeling (AI aka artificial intelligence) to modernize its regulatory process. The goal will be to accelerate the agency’s ability to evaluate medical product innovation. This decision represents a new approach that will use computer models and virtual patients to speed up the approval process.
In July, the FDA released a work plan detailing how it plans to meet requirements of the law—which was intended to accelerate the ability of industr...